Cancer News and Research

Latest Cancer News and Research

New technique can identify cell-secreted proteins

Researchers from North Carolina State University have developed a new technique to identify the proteins secreted by a cell. The new approach should help researchers collect precise data on cell biology, which is critical in fields ranging from zoology to cancer research.

26 Sep 2012

UCSD evaluates safety and tolerability of dexanabinol in Phase I brain cancer study

Researchers at University of California, San Diego Moores Cancer Center are evaluating the safety and tolerability of a synthetic cannabinoid called dexanabinol (ETS2101). Delivered as a weekly intravenous infusion, the drug is being tested in patients with all forms of brain cancer, both primary and metastatic.

26 Sep 2012

New computer program predicts most stable structures of nanometer-sized collagen

The human body is proficient at making collagen. And human laboratories are getting better at it all the time. In a development that could lead to better drug design and new treatments for disease, Rice University researchers have made a major step toward synthesizing custom collagen. Rice scientists who have learned how to make collagen - the fibrous protein that binds cells together into organs and tissues - are now digging into its molecular structure to see how it forms and interacts with biological systems.

26 Sep 2012

Pervenio Lung RS from Life Technologies

Life Technologies Corporation today announced the launch of Pervenio Lung RS. First-of-its-kind, the molecular test has been documented to reliably identify early stage lung cancer patients who are at high risk for mortality following surgery. It also fulfills an unmet need for prognostic information to guide preventative treatment and improve disease management.

25 Sep 2012

EPO grants patent to Aeterna Zentaris’ AEZS-130 for diagnosis of growth hormone deficiency

Aeterna Zentaris Inc. today announced that the European Patent Office has granted a patent for the use of the ghrelin agonist, AEZS-130, related to methods and kits for use in relation to the diagnosis of growth hormone deficiency in a human or animal subject.

25 Sep 2012

OncoSec establishes UW as second enrolling site for OMS-I100 Phase II metastatic melanoma trial

OncoSec Medical Inc., a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that it has established the University of Washington (UW) as the second enrolling site for its Phase II metastatic melanoma clinical trial (OMS-I100).

25 Sep 2012

LIFR protein suppresses local invasion and metastasis of breast cancer cells

A receptor protein suppresses local invasion and metastasis of breast cancer cells, the most lethal aspect of the disease, according to a research team headed by scientists from The University of Texas MD Anderson Cancer Center.

25 Sep 2012

Sarawak Biodiversity Centre in Malaysia, OSU to develop and commercialize anticancer agent

The Ohio State University has signed an agreement with the Sarawak Biodiversity Centre in Malaysia to collaborate on the further development and commercialization of a promising anticancer agent derived from a tropical tree that grows on the island of Borneo.

25 Sep 2012

Researchers discover genetics secrets of ovarian cancer tumors

A new discovery that sheds light on the genetic make up of ovarian cancer cells could explain why some women survive longer than others with this deadly disease.

25 Sep 2012

UH Case Medical Center offers per-oral endoscopic myotomy for achalasia

University Hospitals (UH) Case Medical Center is one of five institutions nationwide performing a novel scarless procedure that restores swallowing function in some patients with achalasia, a rare condition where the esophagus is unable to move food into the stomach.

25 Sep 2012

ProMedica invests $710,000 in new cancer and infusion center in Fostoria, Ohio

Cancer patients in Fostoria, Ohio, now have access to advanced cancer treatment and protocols close to home. The ProMedica Cancer Institute has invested $710,000 in a new cancer and infusion center in Fostoria, Ohio. The rural community has a population of 13,000 residents.

25 Sep 2012

Researchers discover path to identify why genetic variants increase breast cancer risk

Cancer researchers studying 44 known genetic variants associated with breast cancer have found the way to identify why they increase cancer risk, opening the door to future therapeutic applications based on personalized medicine.

25 Sep 2012

State roundup: Anthem dumps Cedars-Sinai, UCLA docs

Two of the most prestigious names in Southern California health care -- Cedars-Sinai and UCLA -- are getting shut out of a major insurance plan for being too expensive. In a bold cost-cutting move, Anthem Blue Cross has eliminated doctors affiliated with the hospitals from a health plan offered to about 60,000 employees and dependents at the cash-strapped city of Los Angeles.

25 Sep 2012

UC Medicine nurses to administer free flu shots to licensed taxicab drivers at O'Hare Midway

As part of an initiative to vaccinate some of Chicago's most vulnerable populations, University of Chicago Medicine nurses will administer free flu shots to licensed taxicab drivers at O'Hare International Airport on Tuesday, Sept. 25, and at Midway International Airport the following Tuesday, Oct. 2. Up to 1,000 cabbies could be vaccinated over the two days.

25 Sep 2012

Public, private sectors must engage to increase chances of success in fighting NCDs

"Some academics and non-profit organizations are skeptical of the motives of the increasing number of multinational companies who seek partnerships to address non-communicable diseases (NCDs)," Derek Yach, senior vice president of global health and agriculture policy at PepsiCo and former head of NCDs at WHO, writes in the Huffington Post's "Impact" blog.

25 Sep 2012

New KSU molecule may deliver drugs inside the body to treat diseases

Kansas State University researchers have discovered a molecule that may be capable of delivering drugs inside the body to treat diseases.

25 Sep 2012

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

There are many different chronic respiratory diseases. Verona Pharma is mainly focused on two diseases: asthma and COPD. Asthma is a very common disease and unfortunately it has been increasing in prevalence in developed countries. This is the same with COPD; however, there may be different reasons for this.

25 Sep 2012

Surgical removal of prostate cancer linked to anxiety, poor sexual satisfaction and depression

Men who undergo surgical removal of prostate cancer can experience significant levels of anxiety one year after surgery, and higher levels of anxiety appear to be linked to poor sexual satisfaction and depression, say researchers at Mayo Clinic's campus in Florida. Their recent study, published in the online edition of Psycho-Oncology, suggests that men who experience high levels of "cancer-specific anxiety" following surgery for prostate cancer could likely benefit from counseling designed to address their worries and improve their quality of life.

25 Sep 2012

Cancer-related medical costs to more than double in some states in less than eight years

Cancer-related medical costs, already a significant portion of overall medical expenses in the United States, will more than double in some states in less than eight years, according to a new study by researchers from RTI International and the Centers for Disease Control and Prevention.

25 Sep 2012

University of Iowa, Mayo Clinic to continue SPORE for lymphoma research

The Mayo Clinic Cancer Center and Holden Comprehensive Cancer Center at the University of Iowa have received a five-year, $11.5 million grant renewal from the National Cancer Institute (NCI) to continue the Specialized Program of Research Excellence (SPORE) for lymphoma research.

25 Sep 2012

Cancer News and Research

Latest Cancer News and Research

New technique can identify cell-secreted proteins

UCSD evaluates safety and tolerability of dexanabinol in Phase I brain cancer study

New computer program predicts most stable structures of nanometer-sized collagen

Pervenio Lung RS from Life Technologies

EPO grants patent to Aeterna Zentaris’ AEZS-130 for diagnosis of growth hormone deficiency

OncoSec establishes UW as second enrolling site for OMS-I100 Phase II metastatic melanoma trial

LIFR protein suppresses local invasion and metastasis of breast cancer cells

Sarawak Biodiversity Centre in Malaysia, OSU to develop and commercialize anticancer agent

Researchers discover genetics secrets of ovarian cancer tumors

UH Case Medical Center offers per-oral endoscopic myotomy for achalasia

ProMedica invests $710,000 in new cancer and infusion center in Fostoria, Ohio

Researchers discover path to identify why genetic variants increase breast cancer risk

State roundup: Anthem dumps Cedars-Sinai, UCLA docs

UC Medicine nurses to administer free flu shots to licensed taxicab drivers at O'Hare Midway

Public, private sectors must engage to increase chances of success in fighting NCDs

New KSU molecule may deliver drugs inside the body to treat diseases

Chronic respiratory disease treatments: an interview with Dr Sven Jan-Anders Karlsson, CEO of Verona Pharma

Surgical removal of prostate cancer linked to anxiety, poor sexual satisfaction and depression

Cancer-related medical costs to more than double in some states in less than eight years

University of Iowa, Mayo Clinic to continue SPORE for lymphoma research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in